Key dates for MRFF 2022 PPHRI Assessment of High-Cost Gene Treatments and Digital Health Interventions Grant Opportunity

  • Release of Funding Rules: 24 October 2022
  • UQ R&I NOI Close: 24 January 2023
  • Applications due to UQ R&I: 31 January 2023
  • Minimum data requirements in Sapphire: 5pm ACT time, 31 January 2023
  • Applications close: 5pm ACT time, 1 March 2023

Overview

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

  • Stream 1 (Targeted Call for Research): develop a generalisable model to support assessment and validation of the clinical effectiveness and cost-effectiveness of new and emerging high upfront-cost therapeutics which includes consideration of ethical, legal, social and cultural aspects.
  • Stream 2 (Targeted Call for Research): conduct an implementation trial in both rural/remote and major city settings utilising the continuous remote monitoring capabilities of pacemakers and implantable cardioverter defibrillators to assess their health and non-health outcomes such as patient preferences, usability and cost effectiveness and appropriateness.
  • Stream 3 (Targeted Call for Research): undertake a retrospective or prospective evaluation of an implementation of a digital health intervention in order to assess the relative impact of augmenting face-to-face care with data from digital tools that advances assessment methods for digital innovations.

Total Funding Available:

  • Stream 1: no minimum, maximum $1.0m for a single grant for up to 2 years
  • Stream 2: no minimum, maximum $1.5m for a single grant for up to 4 years
  • Stream 3: no minimum, maximum $0.75m for a single grant for up to 4 years

A Chief Investigator (CI) must not be named on more than one application submitted to this grant opportunity. Up to 15 CIs may be included as members of the research team.

Note – MRFF grants administered by the NHMRC now require valid Letters of Support from all Partner Organisations included on the application.  We recommend organising these letters as soon as possible during grant preparation, as arranging signature may take some time.  Please consult the Guidelines or the template provided below (coming soon) to ensure that you meet the requirements of a valid Letter of Support.

How to Apply

Internal notice of intent process

All researchers intending to submit an MRFF application are required to submit an internal Notice of Intent. NOIs will be collated centrally and distributed to Faculties and Institutes in order to provide maximum support to the UQ research community.

Step 1.Sapphire updates and scheme reading

  • Register for Sapphire and update your full profile 'My Profile and CV'. The Grant Opportunity will be run through the new National Health and Medical Research Council (NHMRC) grants management system, Sapphire, which replaces RGMS. If any team members are new to Sapphire and need a login/password, start early. The NHMRC require at least three working days to create new Sapphire accounts.
  • Familiarise yourself with the key MRFF, NHMRC and The University of Queensland (UQ) documentation.

Step 2. Completing the application

Step 3. UQ R&I internal review and feedback

  • Ahead of internal review, ensure all online components are complete and valid in Sapphire and CIA has initiated the Certification process. Application errors will be signalled and can be corrected during the Certification stage.
  • To initiate internal review, email your completed Funding Application Coversheet to UQ R&I at mrffgrants@research.uq.edu.au.
  • Internal review by UQ R&I/feedback provided (compliance/eligibility/grantsmanship).

Step 4. Final submission

  • Final submission by UQ R&I to NHMRC.

Readership and researcher support

Before applying, we recommend you:

Key documents

Before applying, please review the full suite of documents available from GrantConnect, the Australian Government grants information system and:

NHMRC

UQ

 

Contact UQ R&I

Round coordinator
Pre-Award Health and International Team